We are live on ! Find out more
LYEL icon

Lyell Immunopharma
LYEL

118 hedge funds and large institutions have $256M invested in Lyell Immunopharma in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 13

42% more capital invested

Capital invested by funds: $180M → $256M (+$76.2M)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

11% more funds holding

Funds holding: 106 → 118 (+12)

10% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 30

0.18% more ownership

Funds ownership: 2.44% → 2.62% (+0.18%)

0% more call options, than puts

Call options by funds: $3K | Put options by funds: $3K

Holders
118
Holders Change
+12
Holders Change %
+11.32%
% of All Funds
1.72%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
25
Increased
33
Reduced
30
Closed
13
Calls
$3K
Puts
$3K
Net Calls
–
Net Calls Change
-$11K

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$4.92M
2
Bank of America
Bank of America
North Carolina
+$1.68M
3
BlackRock
BlackRock
New York
+$1.59M
4
Morgan Stanley
Morgan Stanley
New York
+$1.51M
5
ICM
Invenomic Capital Management
Massachusetts
+$1.34M

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$5.95M
2
State Street
State Street
Massachusetts
-$5.89M
3
FCMI
Foresite Capital Management IV
California
-$828K
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$625K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$478K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
$96.1K – – –
YIH
77
Y-Intercept (HK)
Hong Kong
$94.6K +$87.8K +2,439 New
BFG
78
Bleakley Financial Group
New Jersey
$93.3K +$86.6K +2,405 New
SS
79
Simplicity Solutions
Minnesota
$93.3K +$86.6K +2,405 New
VEA
80
Virtus ETF Advisers
New York
$88.9K +$30.9K +859 +60%
ProShare Advisors
81
ProShare Advisors
Maryland
$86.9K +$10.6K +293 +15%
CANY
82
Caxton Associates (New York)
New York
$73.8K -$289K -8,022 -81%
ASRS
83
Arizona State Retirement System
Arizona
$68.1K -$828 -23 -1%
TRCT
84
Tower Research Capital (TRC)
New York
$64.1K +$6.95K +193 +13%
UBS AM
85
UBS AM
Illinois
$64K – – –
AQR Capital Management
86
AQR Capital Management
Connecticut
$58.7K +$1.19K +33 +2%
Zurich Cantonal Bank
87
Zurich Cantonal Bank
Switzerland
$58K -$11.9K -331 -18%
CUAMC
88
China Universal Asset Management Company
China
$56.5K +$40.9K +1,135 +352%
Teacher Retirement System of Texas
89
Teacher Retirement System of Texas
Texas
$56K -$11.6K -322 -18%
BHCM
90
Brevan Howard Capital Management
Jersey
$50.6K +$47K +1,305 New
GCM
91
Graham Capital Management
Connecticut
$50.2K +$46.6K +1,293 New
SOW
92
State of Wyoming
Wyoming
$41.9K +$38.9K +1,079 New
AP
93
Adero Partners
California
$40.5K – – –
WP
94
Woodline Partners
California
$40.2K – – –
RL
95
RPO LLC
Connecticut
$38.3K +$35.5K +987 New
PCM
96
Prelude Capital Management
New York
$34K +$31.5K +875 New
AIP
97
Ameritas Investment Partners
Nebraska
$33.2K – – –
Victory Capital Management
98
Victory Capital Management
Texas
$32.2K +$6.09K +169 +26%
VPIM
99
Vanguard Personalized Indexing Management
California
$30.9K +$28.7K +796 New
AB
100
Amalgamated Bank
New York
$30K -$3.21K -89 -10%
2 3
4
5 6

LYEL Hedge Fund Activity: Q4 2023 in Review

118 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Lyell Immunopharma (LYEL) for Q4 2023, worth a combined $256M — up 42% from $180M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new LYEL positions and 13 closed out — a net gain of 12 holders — while 33 added to existing stakes and 30 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $4.92M. The largest seller was Vanguard Group, cutting an estimated $5.95M.

  • 118 institutional investors held Lyell Immunopharma (LYEL) as of Q4 2023, up from 106 in Q3 2023.
  • Funds reported $256M of Lyell Immunopharma stock for Q4 2023, up 42% quarter-over-quarter.
  • 25 funds opened new Lyell Immunopharma positions in Q4 2023 and 13 closed out, a net change of +12 holders.
  • The largest Lyell Immunopharma buyer in Q4 2023 was Citadel Advisors, an estimated $4.92M added.
  • The largest Lyell Immunopharma seller in Q4 2023 was Vanguard Group, an estimated $5.95M sold.

Based on aggregated 13F filings for Q4 2023.